דילוג לניווט ראשי דילוג לחיפוש דילוג לתוכן הראשי

SIRT6 overexpression improves various aspects of mouse healthspan

  • Asael Roichman
  • , Yariv Kanfi
  • , Renana Glazz
  • , Shoshana Naiman
  • , Uri Amit
  • , Natalie Landa
  • , Simon Tinman
  • , Ilan Stein
  • , Eli Pikarsky
  • , Jonathan Leor
  • , Haim Y. Cohen

פרסום מחקרי: פרסום בכתב עת › מאמר › ביקורת עמיתים

54 ציטוטים ‏(Scopus)

תקציר

The extension in human lifespan in the last century results in a significant increase in incidence of age related diseases. It is therefore crucial to identify key factors that control elderly healthspan. Similar to dietary restriction, mice overexpressing the NAD+ dependent protein deacylase SIRT6 (MOSES) live longer and have reduced IGF-1 levels. However, it is as yet unknown whether SIRT6 also affects various healthspan parameters. Here, a range of age related phenotypes was evaluated in MOSES mice. In comparison to their wild-type (WT) littermates, old MOSES mice showed amelioration of a variety of age-related disorders, including: improved glucose tolerance, younger hormonal profile, reduced age-related adipose inflammation and increased physical activity. The increased activity was accompanied with increased muscle AMP-activated protein kinase (AMPK) activity. Altogether, these results indicate that overexpression of SIRT6 in mice retards important aspects of the aging process and suggest SIRT6 to be a potential therapeutic target for the treatment of a set of age-related disorders.

שפה מקוריתאנגלית
עמודים (מ-עד)603-615
מספר עמודים13
כתב עתJournals of Gerontology - Series A Biological Sciences and Medical Sciences
כרך72
מספר גיליון5
מזהי עצם דיגיטלי (DOIs)
סטטוס פרסוםפורסם - 2017
פורסם באופן חיצוניכן

טביעת אצבע

להלן מוצגים תחומי המחקר של הפרסום 'SIRT6 overexpression improves various aspects of mouse healthspan'. יחד הם יוצרים טביעת אצבע ייחודית.

פורמט ציטוט ביבליוגרפי